Calcium supplement study for postmenopausal women with osteoporosis
Part of Bones, joints & muscles, Hormones & metabolism clinical trials.
This study tests a new form of calcium (amorphous calcium carbonate) to see if it can improve bone density in postmenopausal women with osteoporosis. It may offer an alternative for women who cannot or choose not to take other osteoporosis medications.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman aged 60 to 90 and have gone through menopause.
- Your bone density test shows osteoporosis (a T-score lower than -2.5, but not below -4.0) in your lower spine or hip.
- You have not taken osteoporosis treatment before, or you have taken a bisphosphonate for less than 3 years and stopped it at least 12 months ago.
- You are willing to take only 400 to 800 IU of extra vitamin D3 per day during the study.
- You can attend all study visits and follow instructions.
- You do not have other bone diseases, recent fractures, or severe vitamin D deficiency.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two osteoporosis drugs (romosozumab and denosumab) given alone or together to see which works better for improving bone density. It may help if you are a postmenopausal woman with osteoporosis and have not taken strong bone medications recently.
This study tests whether denosumab, a medication that strengthens bones, can also improve muscle strength and insulin sensitivity in postmenopausal women with type 2 diabetes who take metformin.
This trial tests whether switching between two medications (Romosozumab and Denosumab) using a cycle or sequence schedule works better for improving bone density in postmenopausal women with severe osteoporosis. It aims to find the most effective treatment plan.
This study compares two medicines (ibandronate and zoledronic acid) to see which one works better at keeping bones strong after stopping denosumab (Prolia). It's for postmenopausal women with mild to moderate bone thinning.
This trial tests if denosumab, a drug that strengthens bones, can help people with type 2 diabetes who have a high risk of breaking a bone. It is for patients who have had diabetes for a long time or have certain complications.
This study looks at how well and how safely another osteoporosis medicine works for people who have already taken denosumab for 2 years. It may help find the best next step to strengthen bones and lower fracture risk after denosumab.
Hear when a new Calcium trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.